Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Evaluating The Effect Of Exemestane In Clinical Stage T1-3 N0-1 M0 Postmenopausal Breast Cancer Patients Completing At Least Five Years Of Tamoxifen Therapy

NCT00016432 is registered in ClinicalTrials.gov with NSABP Foundation Inc as lead sponsor.

NCT NCT00016432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00016432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Evaluating The Effect Of Exemestane In Clinical Stage T1-3 N0-1 M0 Postmenopausal Breast Cancer Patients Completing At Least Five Years Of Tamoxifen Therapy
Lead sponsor
NSABP Foundation Inc
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2001
Completion date
February 28, 2011
Enrollment
1,598 (actual)
Sites
162

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer